Loading insider details...
Latest Form 4 (Nov 6, 2026): Exercise/Conversion of 1,250 JAZZ shares, $175.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Exercise/Conversion | 1,250 | $175.0K |
| Mar 9, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 1,436 | $268.2K |
| Mar 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 2,223 | n/a |
| Jan 22, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 2,370 | n/a |
| Dec 9, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 160 | $27.4K |
| Nov 20, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 69 | $12.5K |
| Mar 11, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to Issuer | 1,333 | $184.3K |
| Mar 4, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Exercise/Conversion | 4,500 | $508.9K |
| Jan 22, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 1,641 | n/a |
| Dec 4, 2024 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 53 | $6.5K |